BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T070000
DTEND;TZID=America/New_York:20190912T180000
DTSTAMP:20190815T154121Z
CREATED:20190815T153644Z
LAST-MODIFIED:20190815T154121Z
UID:6196-1568012400-1568311200@scienceinboston.com
SUMMARY:AI Applications for Drug Discovery and Development
DESCRIPTION:Connect with key stakeholders in pharma and biotech to transform scientific research based on better decision-making\, optimized innovation\, improved efficiency of clinical trials\, and new tool creation for physicians\, consumers\, insurers\, and regulators at this year’s AI conference. The program consists of two full days of case studies that will give you the opportunity to learn how to improve R&D productivity\, expedite timelines & identify better drug candidates from target identification right through to post market. The 3rd day\, September 12\, is a dedicated partnering day offering you the opportunity to meet with industry\, academia\, consortia\, associations and tech providers to discuss the hottest trends and innovation in pharma and healthcare to date. \nMassBio member companies can save 10% off the current rate when you register online with VIP code MASSBIO (new registrations only). For full program details and to register\, visit our website.
URL:https://scienceinboston.com/event/ai-applications-for-drug-discovery-and-development/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T070000
DTEND;TZID=America/New_York:20190912T180000
DTSTAMP:20190815T153644Z
CREATED:20190815T153644Z
LAST-MODIFIED:20190815T153644Z
UID:27313-1568012400-1568311200@scienceinboston.com
SUMMARY:AI Applications for Drug Discovery and Development
DESCRIPTION:Connect with key stakeholders in pharma and biotech to transform scientific research based on better decision-making\, optimized innovation\, improved efficiency of clinical trials\, and new tool creation for physicians\, consumers\, insurers\, and regulators at this year’s AI conference. The program consists of two full days of case studies that will give you the opportunity to learn how to improve R&D productivity\, expedite timelines & identify better drug candidates from target identification right through to post market. The 3rd day\, September 12\, is a dedicated partnering day offering you the opportunity to meet with industry\, academia\, consortia\, associations and tech providers to discuss the hottest trends and innovation in pharma and healthcare to date. \nMassBio member companies can save 10% off the current rate when you register online with VIP code MASSBIO (new registrations only). For full program details and to register\, visit our website.
URL:https://scienceinboston.com/event/ai-applications-for-drug-discovery-and-development-2/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T113000
DTEND;TZID=America/New_York:20190906T143000
DTSTAMP:20190815T152807Z
CREATED:20190815T151253Z
LAST-MODIFIED:20190815T152807Z
UID:6192-1567769400-1567780200@scienceinboston.com
SUMMARY:Poretta & Orr Lunch & Learn: Maximize Convention Marketing Results - Successful Strategies for Biotechs - Pre-Launch Through Maturity
DESCRIPTION:Sometimes you just don’t know what you don’t know. If you work for a bio start-up or a company that is launching a new drug or device be sure you start thinking of your marketing end game right out of the gate! Knowing where you want to end up is vital to creating a successful strategy from the start. So mark your calendars now! Join MassBio member Poretta & Orr for an informative and interactive Lunch & Learn as we discuss the strategy behind a successful framework for convention planning\, including identification of essential partners and their roles. \n\nRob Metz\, Senior Vice President\, Global Business Operations & Chief Compliance Officer at Horizon Therapeutics is showcased in video clips and interviews that highlight Horizon Therapeutics strategic use of conventions through several phases of company growth and product life cycle.\nA review of best practices relating to conventions\, pre-launch and launch phases is reviewed.\nBest practices pertaining to planning and program evaluation is also a critical component of a successful convention marketing program and discussed.\nAgency collaboration processes and success stories are shared.\n\nRemember\, having a strategy from the beginning is vital to successful\, creative and memorable convention and exhibit marketing. Come ask your questions\, enjoy a delicious lunch and let’s get acquainted!
URL:https://scienceinboston.com/event/poretta-orr-lunch-learn-maximize-convention-marketing-results-successful-strategies-for-biotechs-pre-launch-through-maturity/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T113000
DTEND;TZID=America/New_York:20190906T143000
DTSTAMP:20190815T151253Z
CREATED:20190815T151253Z
LAST-MODIFIED:20190815T151253Z
UID:27310-1567769400-1567780200@scienceinboston.com
SUMMARY:Poretta & Orr Lunch & Learn: Maximize Convention Marketing Results - Successful Strategies for Biotechs - Pre-Launch Through Maturity
DESCRIPTION:Sometimes you just don’t know what you don’t know. If you work for a bio start-up or a company that is launching a new drug or device be sure you start thinking of your marketing end game right out of the gate! Knowing where you want to end up is vital to creating a successful strategy from the start. So mark your calendars now! Join MassBio member Poretta & Orr for an informative and interactive Lunch & Learn as we discuss the strategy behind a successful framework for convention planning\, including identification of essential partners and their roles. \n\nRob Metz\, Senior Vice President\, Global Business Operations & Chief Compliance Officer at Horizon Therapeutics is showcased in video clips and interviews that highlight Horizon Therapeutics strategic use of conventions through several phases of company growth and product life cycle.\nA review of best practices relating to conventions\, pre-launch and launch phases is reviewed.\nBest practices pertaining to planning and program evaluation is also a critical component of a successful convention marketing program and discussed.\nAgency collaboration processes and success stories are shared.\n\nRemember\, having a strategy from the beginning is vital to successful\, creative and memorable convention and exhibit marketing. Come ask your questions\, enjoy a delicious lunch and let’s get acquainted!
URL:https://scienceinboston.com/event/poretta-orr-lunch-learn-maximize-convention-marketing-results-successful-strategies-for-biotechs-pre-launch-through-maturity-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T083000
DTEND;TZID=America/New_York:20190906T180000
DTSTAMP:20190816T142747Z
CREATED:20190816T142747Z
LAST-MODIFIED:20190816T142747Z
UID:6209-1567758600-1567792800@scienceinboston.com
SUMMARY:2nd Annual Dana-Farber Chemical Biology Symposium
DESCRIPTION:We are approaching our capacity for registered attendees at this time! Please add your name to the wait list through EventBrite and we will let you know if space opens up!\n\nWe are delighted to welcome you to the 2nd Annual Dana-Farber Cancer Institute (DFCI) Chemical Biology Symposium! \nThis symposium aims to bring together speakers representing a diverse range of chemical biology research interests\, and highlight important insights\, developments\, and contributions to this unique field. We are excited to include an afternoon career panel discussion in addition to scientific talks. This day-long event is free to attend and open to the public. \nEarly evening poster session and reception to follow talks and afternoon career panel. \nRegistered attendees are also invited to submit poster abstracts here. \nAbstract deadline: August 19\, 2019 \nEvent Agenda\n8:00 – 8:30 AM Arrival and Registration (Coffee will be provided) \n8:30 – 8:45 AM Welcome Remarks \n8:45 – 9:30 AM Keynote Address\nMarion Dorsch \, Ph.D.\, Chief Scientific Officer\, Blueprint Medicines\n“Unlocking the full potential of kinase medicines: highly selective therapies for genomically defined diseases”\n9:30 – 10:00 AM Katya Marjon\, Agios “Targeting MAT2A in MTAP-deleted Cancers.” \n10:00 – 10:30 AM Sloan Devlin\, Harvard Medical School “Bacterial modifications of host metabolites alter host physiology” \n10:30 – 11:00 AM\, Coffee Break\, Jimmy Fund Auditorium Lobby \n11:00 – 11:30 AM Nathalie Agar\, Brigham And Women’s Hospital and Harvard Medical School \n11:30 AM – 12:00 PM Jeremy Jenkins\, Novartis Institute for BioMedical Research (NIBR)\, “Technology advances for characterizing compound MOA” \n12:00 – 1:00 PM Lunch on your own \n1:00 – 1:30 PM Angela Koehler\, Koch Institute at MIT\, “Attenuating Oncogenic Transcription with Small Molecules” \n1:30 – 2:00 PM Eric Fischer\, Dana-Farber Cancer Institute and Harvard Medical School “Principles of small molecule mediated ubiquitin ligase targeting” \n2:00 – 3:00 PM Career Panel Discussion: Christopher Browne (AstraZeneca)\, Janet Ralbovsky (Dana-Farber)\, Mishtu Dey (Cell Press)\, and Dora Carrico-Moniz (Wellesley College) \n3:00 – 3:15 PM Coffee Break\, Jimmy Fund Auditorium Lobby \n3:15 – 4:00 PM Keynote Address\nGarry Nolan\, Ph.D.\, Stanford University School of Medicine\n“Pathology from the molecular scale on up”\n4:00 – 4:05 PM Closing Remarks \n4:05 – 6:00 PM Poster Reception with Light Refreshments\, Yawkey Conference Center \n(submit your posters here) \nTo learn more about this event\, email the DFCI Chemical Biology Program at chemical_biology@dfci.harvard.edu\, or follow us on Twitter at @DFCI_ChemBio #DFCIChemBio2019 \nTo learn more about Chemical Biology @DFCI visit our website. \nDownload our event flyer here and spread the word! \nSee you there!
URL:https://scienceinboston.com/event/2nd-annual-dana-farber-chemical-biology-symposium/
LOCATION:Jimmy Fund Auditorium\, 35 Binney St\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T083000
DTEND;TZID=America/New_York:20190906T180000
DTSTAMP:20190816T142747Z
CREATED:20190816T142747Z
LAST-MODIFIED:20190816T142747Z
UID:27316-1567758600-1567792800@scienceinboston.com
SUMMARY:2nd Annual Dana-Farber Chemical Biology Symposium
DESCRIPTION:We are approaching our capacity for registered attendees at this time! Please add your name to the wait list through EventBrite and we will let you know if space opens up!\n\nWe are delighted to welcome you to the 2nd Annual Dana-Farber Cancer Institute (DFCI) Chemical Biology Symposium! \nThis symposium aims to bring together speakers representing a diverse range of chemical biology research interests\, and highlight important insights\, developments\, and contributions to this unique field. We are excited to include an afternoon career panel discussion in addition to scientific talks. This day-long event is free to attend and open to the public. \nEarly evening poster session and reception to follow talks and afternoon career panel. \nRegistered attendees are also invited to submit poster abstracts here. \nAbstract deadline: August 19\, 2019 \nEvent Agenda\n8:00 – 8:30 AM Arrival and Registration (Coffee will be provided) \n8:30 – 8:45 AM Welcome Remarks \n8:45 – 9:30 AM Keynote Address\nMarion Dorsch \, Ph.D.\, Chief Scientific Officer\, Blueprint Medicines\n“Unlocking the full potential of kinase medicines: highly selective therapies for genomically defined diseases”\n9:30 – 10:00 AM Katya Marjon\, Agios “Targeting MAT2A in MTAP-deleted Cancers.” \n10:00 – 10:30 AM Sloan Devlin\, Harvard Medical School “Bacterial modifications of host metabolites alter host physiology” \n10:30 – 11:00 AM\, Coffee Break\, Jimmy Fund Auditorium Lobby \n11:00 – 11:30 AM Nathalie Agar\, Brigham And Women’s Hospital and Harvard Medical School \n11:30 AM – 12:00 PM Jeremy Jenkins\, Novartis Institute for BioMedical Research (NIBR)\, “Technology advances for characterizing compound MOA” \n12:00 – 1:00 PM Lunch on your own \n1:00 – 1:30 PM Angela Koehler\, Koch Institute at MIT\, “Attenuating Oncogenic Transcription with Small Molecules” \n1:30 – 2:00 PM Eric Fischer\, Dana-Farber Cancer Institute and Harvard Medical School “Principles of small molecule mediated ubiquitin ligase targeting” \n2:00 – 3:00 PM Career Panel Discussion: Christopher Browne (AstraZeneca)\, Janet Ralbovsky (Dana-Farber)\, Mishtu Dey (Cell Press)\, and Dora Carrico-Moniz (Wellesley College) \n3:00 – 3:15 PM Coffee Break\, Jimmy Fund Auditorium Lobby \n3:15 – 4:00 PM Keynote Address\nGarry Nolan\, Ph.D.\, Stanford University School of Medicine\n“Pathology from the molecular scale on up”\n4:00 – 4:05 PM Closing Remarks \n4:05 – 6:00 PM Poster Reception with Light Refreshments\, Yawkey Conference Center \n(submit your posters here) \nTo learn more about this event\, email the DFCI Chemical Biology Program at chemical_biology@dfci.harvard.edu\, or follow us on Twitter at @DFCI_ChemBio #DFCIChemBio2019 \nTo learn more about Chemical Biology @DFCI visit our website. \nDownload our event flyer here and spread the word! \nSee you there!
URL:https://scienceinboston.com/event/2nd-annual-dana-farber-chemical-biology-symposium-2/
LOCATION:Jimmy Fund Auditorium\, 35 Binney St\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190905T170000
DTEND;TZID=America/New_York:20190905T190000
DTSTAMP:20190821T150343Z
CREATED:20190821T150343Z
LAST-MODIFIED:20190821T150343Z
UID:6295-1567702800-1567710000@scienceinboston.com
SUMMARY:STEMCELL Career Open House
DESCRIPTION:After a busy day in the lab\, join us for wine and cheese at the annual STEMCELL Career Open House in Kendall Square. \nSpace is limited. Please RSVP before September 4\, 2019 to reserve your spot! \n\n\n\n\nTimeThursday\, September 5\, 2019\, 5:00 pm – 7:00 pm \nLocationSTEMCELL Technologies Inc. Cambridge Office\n2323 – 222 Third Street\, Cambridge\, MA
URL:https://scienceinboston.com/event/stemcell-career-open-house/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190905T170000
DTEND;TZID=America/New_York:20190905T190000
DTSTAMP:20190821T150343Z
CREATED:20190821T150343Z
LAST-MODIFIED:20190821T150343Z
UID:27323-1567702800-1567710000@scienceinboston.com
SUMMARY:STEMCELL Career Open House
DESCRIPTION:After a busy day in the lab\, join us for wine and cheese at the annual STEMCELL Career Open House in Kendall Square. \nSpace is limited. Please RSVP before September 4\, 2019 to reserve your spot! \n\n\n\n\nTimeThursday\, September 5\, 2019\, 5:00 pm – 7:00 pm \nLocationSTEMCELL Technologies Inc. Cambridge Office\n2323 – 222 Third Street\, Cambridge\, MA
URL:https://scienceinboston.com/event/stemcell-career-open-house-2/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190903T100000
DTEND;TZID=America/New_York:20190903T180000
DTSTAMP:20190815T152831Z
CREATED:20190815T151042Z
LAST-MODIFIED:20190815T152831Z
UID:6189-1567504800-1567533600@scienceinboston.com
SUMMARY:Bridging the Gap Symposium
DESCRIPTION:The GSAS Harvard Biotechnology Club 20th anniversary symposium will celebrate 20 years of student-driven connections between academia and industry. This meeting will highlight seminal achievements in biotech innovation and commercialization that have occurred since the inception of the club in 1999\, especially those which have made a measurable impact on patients’ lives. A theme of fostered collaboration between industry and academia will be emphasized\, with panels covering the work of entrepreneurial academic investigators and the bond of information transfer between academia and industry. Keynote speakers will provide outlooks on the unique roles of academia and industry in the ecosystem of biotechnology\, and will feature Dean George Daley of Harvard Medical School\, RA Capital Founder and Managing Director Peter Kolchinsky\, and Vertex EVP & CSO David Altshuler. The GSAS Harvard Biotechnology Club is excited to host this meeting as one of its premier initiatives for students seeking futures in biotechnology. \nWhether you’re a prospective or current student\, recent graduate or postdoc\, industry professional or retiree\, we invite you to attend our symposium that will celebrate our 20th year as an organization.
URL:https://scienceinboston.com/event/bridging-the-gap-symposium/
LOCATION:GSAS Harvard Biotech Club\, 423 Brookline Ave.\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190903T100000
DTEND;TZID=America/New_York:20190903T180000
DTSTAMP:20190815T151042Z
CREATED:20190815T151042Z
LAST-MODIFIED:20190815T151042Z
UID:27309-1567504800-1567533600@scienceinboston.com
SUMMARY:Bridging the Gap Symposium
DESCRIPTION:The GSAS Harvard Biotechnology Club 20th anniversary symposium will celebrate 20 years of student-driven connections between academia and industry. This meeting will highlight seminal achievements in biotech innovation and commercialization that have occurred since the inception of the club in 1999\, especially those which have made a measurable impact on patients’ lives. A theme of fostered collaboration between industry and academia will be emphasized\, with panels covering the work of entrepreneurial academic investigators and the bond of information transfer between academia and industry. Keynote speakers will provide outlooks on the unique roles of academia and industry in the ecosystem of biotechnology\, and will feature Dean George Daley of Harvard Medical School\, RA Capital Founder and Managing Director Peter Kolchinsky\, and Vertex EVP & CSO David Altshuler. The GSAS Harvard Biotechnology Club is excited to host this meeting as one of its premier initiatives for students seeking futures in biotechnology. \nWhether you’re a prospective or current student\, recent graduate or postdoc\, industry professional or retiree\, we invite you to attend our symposium that will celebrate our 20th year as an organization.
URL:https://scienceinboston.com/event/bridging-the-gap-symposium-2/
LOCATION:GSAS Harvard Biotech Club\, 423 Brookline Ave.\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190822T133000
DTEND;TZID=America/New_York:20190822T153000
DTSTAMP:20190723T204745Z
CREATED:20190723T204745Z
LAST-MODIFIED:20190723T204745Z
UID:6000-1566480600-1566487800@scienceinboston.com
SUMMARY:MassBio Backyard Bash With World Series Trophies
DESCRIPTION:In the 2018 World Series\, the Boston Red Sox cruised to victory against the Los Angeles Dodgers. \nOn August 22nd\, that very trophy will be coming to MassBio for our first Backyard Bash. Join us in the Technology Square courtyard for sausages\, hot dogs\, a firetruck turned pizza oven\, and a photo opp with the World Series trophies. MassBio members only. Registration and a printed ticket is required for entry.
URL:https://scienceinboston.com/event/massbio-backyard-bash-with-world-series-trophies/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190822T133000
DTEND;TZID=America/New_York:20190822T153000
DTSTAMP:20190723T204745Z
CREATED:20190723T204745Z
LAST-MODIFIED:20190723T204745Z
UID:27305-1566480600-1566487800@scienceinboston.com
SUMMARY:MassBio Backyard Bash With World Series Trophies
DESCRIPTION:In the 2018 World Series\, the Boston Red Sox cruised to victory against the Los Angeles Dodgers. \nOn August 22nd\, that very trophy will be coming to MassBio for our first Backyard Bash. Join us in the Technology Square courtyard for sausages\, hot dogs\, a firetruck turned pizza oven\, and a photo opp with the World Series trophies. MassBio members only. Registration and a printed ticket is required for entry.
URL:https://scienceinboston.com/event/massbio-backyard-bash-with-world-series-trophies-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190821T120000
DTEND;TZID=America/Vancouver:20190821T130000
DTSTAMP:20190810T201259Z
CREATED:20190810T201259Z
LAST-MODIFIED:20190810T201259Z
UID:6160-1566388800-1566392400@scienceinboston.com
SUMMARY:HCBI Lunch and Learn Lecture Series
DESCRIPTION:Image analysis pipelines with KNIME and Ilastik – demonstrate building image analysis pipelines with KNIME\, using interactive image segmentation with Ilastik as an example. KNIME integrates all steps of image analysis into a manageable\, nodebased workflow and is compatible with ImageJ\, MATLAB\, etc. (Andrew Seeber)
URL:https://scienceinboston.com/event/hcbi-lunch-and-learn-lecture-series-2/
LOCATION:Biological Laboratories\, 16 Divinity Avenue Biological Labs Lecture Hall\, Room 1080\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190821T120000
DTEND;TZID=America/Vancouver:20190821T130000
DTSTAMP:20190810T201259Z
CREATED:20190810T201259Z
LAST-MODIFIED:20190810T201259Z
UID:27307-1566388800-1566392400@scienceinboston.com
SUMMARY:HCBI Lunch and Learn Lecture Series
DESCRIPTION:Image analysis pipelines with KNIME and Ilastik – demonstrate building image analysis pipelines with KNIME\, using interactive image segmentation with Ilastik as an example. KNIME integrates all steps of image analysis into a manageable\, nodebased workflow and is compatible with ImageJ\, MATLAB\, etc. (Andrew Seeber)
URL:https://scienceinboston.com/event/hcbi-lunch-and-learn-lecture-series-2-2/
LOCATION:Biological Laboratories\, 16 Divinity Avenue Biological Labs Lecture Hall\, Room 1080\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190815T170000
DTEND;TZID=America/Vancouver:20190815T190000
DTSTAMP:20190723T205025Z
CREATED:20190723T205025Z
LAST-MODIFIED:20190723T205025Z
UID:6002-1565888400-1565895600@scienceinboston.com
SUMMARY:MassBio Regional Mixer: Woburn
DESCRIPTION:Join MassBio for a Regional Mixer in Woburn! This growing area is home to many MassBio members\, and a key part of the local life sciences scene. MassBio members\, if you work or live in or around Woburn\, this is your chance to kick back with your coworkers and network. Never been to a MassBio event? This is a great event to start with! Regular attendee? Invite a coworker that’s never been. Appetizers and drinks will be served. \nMassBio members only. Registration required.
URL:https://scienceinboston.com/event/massbio-regional-mixer-woburn/
LOCATION:Strega Prime Woburn\, 100 Sylvan Rd\, Worburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190815T170000
DTEND;TZID=America/Vancouver:20190815T190000
DTSTAMP:20190723T205025Z
CREATED:20190723T205025Z
LAST-MODIFIED:20190723T205025Z
UID:27306-1565888400-1565895600@scienceinboston.com
SUMMARY:MassBio Regional Mixer: Woburn
DESCRIPTION:Join MassBio for a Regional Mixer in Woburn! This growing area is home to many MassBio members\, and a key part of the local life sciences scene. MassBio members\, if you work or live in or around Woburn\, this is your chance to kick back with your coworkers and network. Never been to a MassBio event? This is a great event to start with! Regular attendee? Invite a coworker that’s never been. Appetizers and drinks will be served. \nMassBio members only. Registration required.
URL:https://scienceinboston.com/event/massbio-regional-mixer-woburn-2/
LOCATION:Strega Prime Woburn\, 100 Sylvan Rd\, Worburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190814T120000
DTEND;TZID=America/New_York:20190814T123000
DTSTAMP:20190723T204148Z
CREATED:20190723T204148Z
LAST-MODIFIED:20190723T204148Z
UID:5997-1565784000-1565785800@scienceinboston.com
SUMMARY:Current and Future Trends in Oncology Care Delivery
DESCRIPTION:According to the American Cancer Society\, each year more than 1.7 million new cases of cancer are diagnosed. By 2020\, 18 million cancer survivors are expected in the United States alone. Emerging research and technologies are helping to rapidly change the pace of oncology discovery\, innovation and treatment. As a result\, high costs\, survivorship\, and a focus on patient-driven care are transforming how cancer care is delivered. \nIn this webinar\, Mara Bloom\, JD\, MS\, Executive Director of the Massachusetts General Hospital Cancer Center\, will present the cancer center as a case study for how we can use service line management to engage stakeholders and streamline healthcare delivery\, reduce costs\, improve patient experience and encourage continued innovation and growth. She will also discuss how a multidisciplinary care model leads to greater collaboration among physicians and researchers. Bloom also will highlight how the latest therapies\, technologies and care models\, including home hospital\, telemedicine and artificial intelligence will help shape the cancer center of the future.
URL:https://scienceinboston.com/event/current-and-future-trends-in-oncology-care-delivery/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190814T120000
DTEND;TZID=America/New_York:20190814T123000
DTSTAMP:20190723T204148Z
CREATED:20190723T204148Z
LAST-MODIFIED:20190723T204148Z
UID:27304-1565784000-1565785800@scienceinboston.com
SUMMARY:Current and Future Trends in Oncology Care Delivery
DESCRIPTION:According to the American Cancer Society\, each year more than 1.7 million new cases of cancer are diagnosed. By 2020\, 18 million cancer survivors are expected in the United States alone. Emerging research and technologies are helping to rapidly change the pace of oncology discovery\, innovation and treatment. As a result\, high costs\, survivorship\, and a focus on patient-driven care are transforming how cancer care is delivered. \nIn this webinar\, Mara Bloom\, JD\, MS\, Executive Director of the Massachusetts General Hospital Cancer Center\, will present the cancer center as a case study for how we can use service line management to engage stakeholders and streamline healthcare delivery\, reduce costs\, improve patient experience and encourage continued innovation and growth. She will also discuss how a multidisciplinary care model leads to greater collaboration among physicians and researchers. Bloom also will highlight how the latest therapies\, technologies and care models\, including home hospital\, telemedicine and artificial intelligence will help shape the cancer center of the future.
URL:https://scienceinboston.com/event/current-and-future-trends-in-oncology-care-delivery-2/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190813T113000
DTEND;TZID=America/Vancouver:20190813T130000
DTSTAMP:20190810T201602Z
CREATED:20190810T201602Z
LAST-MODIFIED:20190810T201602Z
UID:6161-1565695800-1565701200@scienceinboston.com
SUMMARY:Lunch & Learn: Structural Modeling of Textile-Reinforced\, Tissue-Engineered Heart Valves
DESCRIPTION:Heart valve defects or diseases can be very serious\, often requiring valve replacement.  Traditional synthetic heart valves can calcify or wear over time and the surgeries required can carry high risk and be very invasive.  To address these drawbacks\, researchers are developing tissue-engineered heart valves which can be inserted orthoscopically.  These tissue-engineered heart valves have the potential to make compatible and effective replacements\, but they are currently not strong enough to survive the high pressures found on the aortic side of the heart.  To strengthen the valves\, the tissue is grown around a textile reinforcement: too little reinforcement and the valve tears\, too much and it does not function correctly.  This presentation\, by UMass Lowell Professor Scott Stapleton of mechanical engineering\, will summarize efforts to computationally model the hierarchical heart valve structure\, with the intent of designing and optimizing textile reinforcement to strengthen the valve while maintaining its proper function.
URL:https://scienceinboston.com/event/lunch-learn-structural-modeling-of-textile-reinforced-tissue-engineered-heart-valves/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190813T113000
DTEND;TZID=America/Vancouver:20190813T130000
DTSTAMP:20190810T201602Z
CREATED:20190810T201602Z
LAST-MODIFIED:20190810T201602Z
UID:27308-1565695800-1565701200@scienceinboston.com
SUMMARY:Lunch & Learn: Structural Modeling of Textile-Reinforced\, Tissue-Engineered Heart Valves
DESCRIPTION:Heart valve defects or diseases can be very serious\, often requiring valve replacement.  Traditional synthetic heart valves can calcify or wear over time and the surgeries required can carry high risk and be very invasive.  To address these drawbacks\, researchers are developing tissue-engineered heart valves which can be inserted orthoscopically.  These tissue-engineered heart valves have the potential to make compatible and effective replacements\, but they are currently not strong enough to survive the high pressures found on the aortic side of the heart.  To strengthen the valves\, the tissue is grown around a textile reinforcement: too little reinforcement and the valve tears\, too much and it does not function correctly.  This presentation\, by UMass Lowell Professor Scott Stapleton of mechanical engineering\, will summarize efforts to computationally model the hierarchical heart valve structure\, with the intent of designing and optimizing textile reinforcement to strengthen the valve while maintaining its proper function.
URL:https://scienceinboston.com/event/lunch-learn-structural-modeling-of-textile-reinforced-tissue-engineered-heart-valves-2/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190808T113000
DTEND;TZID=America/New_York:20190808T130000
DTSTAMP:20190723T203946Z
CREATED:20190723T203946Z
LAST-MODIFIED:20190723T203946Z
UID:5996-1565263800-1565269200@scienceinboston.com
SUMMARY:Lunch & Learn: Small Business Innovation Research Grant
DESCRIPTION:Do you have the next great tech idea? \nThe Small Business Innovation Research Program (SBIR) is a $2.4 billion federal grant program established to support R&D that has potential for commercialization. \nDan Lilly\, Small Business Innovation Research Advisor\,  will provide an overview of the SBIR program\, including information on the program’s purpose\, eligibility\, sources of funding\, and foundational knowledge of what is necessary to succeed. \nThis seminar is designed to help you determine if the program is right for you\, and to begin efforts to develop an SBIR proposal.
URL:https://scienceinboston.com/event/lunch-learn-small-business-innovation-research-grant/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190808T113000
DTEND;TZID=America/New_York:20190808T130000
DTSTAMP:20190723T203946Z
CREATED:20190723T203946Z
LAST-MODIFIED:20190723T203946Z
UID:27303-1565263800-1565269200@scienceinboston.com
SUMMARY:Lunch & Learn: Small Business Innovation Research Grant
DESCRIPTION:Do you have the next great tech idea? \nThe Small Business Innovation Research Program (SBIR) is a $2.4 billion federal grant program established to support R&D that has potential for commercialization. \nDan Lilly\, Small Business Innovation Research Advisor\,  will provide an overview of the SBIR program\, including information on the program’s purpose\, eligibility\, sources of funding\, and foundational knowledge of what is necessary to succeed. \nThis seminar is designed to help you determine if the program is right for you\, and to begin efforts to develop an SBIR proposal.
URL:https://scienceinboston.com/event/lunch-learn-small-business-innovation-research-grant-2/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190807T110000
DTEND;TZID=America/New_York:20190807T130000
DTSTAMP:20190723T203334Z
CREATED:20190723T203334Z
LAST-MODIFIED:20190723T203334Z
UID:5994-1565175600-1565182800@scienceinboston.com
SUMMARY:MassBio Edge Summer Supplier Series: Woburn
DESCRIPTION:Join MassBio for our annual Summer Supplier Series. Stop by during your lunch time hour to enjoy free pizza. MassBio’s Preferred Partners and Fisher Scientific’s preferred suppliers will showcase the latest technologies\, equipment\, supplies and services.\nNo online registration required. \nVendors Include: \nCorning\nSpringer Nature\nEppendorf\nAlert Scientific\nStericycle\nGilson\nFisher Scientific\nMiddlesex Gases & Technologies\nW.B. Mason\nVeolia\nIPP\nAFR\nMicros Northeast\nFlight Centre Travel\nBiotix\nKimberly Clark\nGE\nBiotek\nBiotix
URL:https://scienceinboston.com/event/massbio-edge-summer-supplier-series-woburn/
LOCATION:Building Lobby\, 19 Presidential Way\, Woburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190807T110000
DTEND;TZID=America/New_York:20190807T130000
DTSTAMP:20190723T203334Z
CREATED:20190723T203334Z
LAST-MODIFIED:20190723T203334Z
UID:27302-1565175600-1565182800@scienceinboston.com
SUMMARY:MassBio Edge Summer Supplier Series: Woburn
DESCRIPTION:Join MassBio for our annual Summer Supplier Series. Stop by during your lunch time hour to enjoy free pizza. MassBio’s Preferred Partners and Fisher Scientific’s preferred suppliers will showcase the latest technologies\, equipment\, supplies and services.\nNo online registration required. \nVendors Include: \nCorning\nSpringer Nature\nEppendorf\nAlert Scientific\nStericycle\nGilson\nFisher Scientific\nMiddlesex Gases & Technologies\nW.B. Mason\nVeolia\nIPP\nAFR\nMicros Northeast\nFlight Centre Travel\nBiotix\nKimberly Clark\nGE\nBiotek\nBiotix
URL:https://scienceinboston.com/event/massbio-edge-summer-supplier-series-woburn-2/
LOCATION:Building Lobby\, 19 Presidential Way\, Woburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190807T080000
DTEND;TZID=America/Vancouver:20190807T160000
DTSTAMP:20190723T202845Z
CREATED:20190723T202845Z
LAST-MODIFIED:20190723T202845Z
UID:5992-1565164800-1565193600@scienceinboston.com
SUMMARY:Paying for Cures Workshop at MIT
DESCRIPTION:Survey the financial challenges of sustaining new cell and gene therapies\, and anticipate coming changes in policy and practice\n\n\n\n\n\n\nAbout this Event\n\n\nDurable\, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits\, but large single payments will challenge the current reimbursement system. Policy\, regulations\, and business operations need to evolve to enable emerging solutions. \nThis intensive 1-day workshop at MIT will include: \n\nAn overview of cell and gene therapies’ unique and challenging characteristics\nInsights on the financial issues and impacts of performance-based agreements for new therapies\nA discussion of evolving policy and legistative changes\nInteraction with sector thought leaders and MIT researchers\n\nThis interactive workshop is ideal for: \n\nHealthcare policy consultants and analysts\nIndustry / trade group strategists\nAcademic researchers\nPatient advocates\n\n50% discount for FoCUS Project Sponsors. Please contact Katie Torrence to get the code for automatic discount at registration.
URL:https://scienceinboston.com/event/paying-for-cures-workshop-at-mit/
LOCATION:MIT Samberg Conference Center\, Salon I/T\, 50 Memorial Drive\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190807T080000
DTEND;TZID=America/Vancouver:20190807T160000
DTSTAMP:20190723T202845Z
CREATED:20190723T202845Z
LAST-MODIFIED:20190723T202845Z
UID:27301-1565164800-1565193600@scienceinboston.com
SUMMARY:Paying for Cures Workshop at MIT
DESCRIPTION:Survey the financial challenges of sustaining new cell and gene therapies\, and anticipate coming changes in policy and practice\n\n\n\n\n\n\nAbout this Event\n\n\nDurable\, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits\, but large single payments will challenge the current reimbursement system. Policy\, regulations\, and business operations need to evolve to enable emerging solutions. \nThis intensive 1-day workshop at MIT will include: \n\nAn overview of cell and gene therapies’ unique and challenging characteristics\nInsights on the financial issues and impacts of performance-based agreements for new therapies\nA discussion of evolving policy and legistative changes\nInteraction with sector thought leaders and MIT researchers\n\nThis interactive workshop is ideal for: \n\nHealthcare policy consultants and analysts\nIndustry / trade group strategists\nAcademic researchers\nPatient advocates\n\n50% discount for FoCUS Project Sponsors. Please contact Katie Torrence to get the code for automatic discount at registration.
URL:https://scienceinboston.com/event/paying-for-cures-workshop-at-mit-2/
LOCATION:MIT Samberg Conference Center\, Salon I/T\, 50 Memorial Drive\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190805T093000
DTEND;TZID=America/New_York:20190805T140000
DTSTAMP:20190723T202650Z
CREATED:20190723T202609Z
LAST-MODIFIED:20190723T202650Z
UID:5991-1564997400-1565013600@scienceinboston.com
SUMMARY:Overview of the Anticipated Environmental Risk Assessment Guideline Revisions\, with Selected Case Studies and Perspectives from Industry Experts
DESCRIPTION:Presentation Topics: \nNotable Changes to the Existing European Medicines Agency Guideline for ERA: How Revisions Could Affect Testing and Environmental Risk Assessment of Human Drugs\nSpeaker: Dr. Erick Nfon\, Smithers Viscient \n\nIntroduction of a decision tree that clarifies when ERA studies are required\nNew guidance for the estimation of exposure to human pharmaceuticals via the food chain (secondary poisoning)\nRevision to the tiered approach to laboratory testing\nIntroduction of tailored risk assessments for active substances with specific modes of action\, e.g. antimicrobials and Endocrine Active Substances\n\nEnvironmental Assessment of New Human Drugs: Case studies and Lessons Learned\nSpeaker: Dr. Tim Verslycke\, Gradient \n\nChanges in drug R&D are increasingly requiring a tailored environmental assessment approach\nReal case studies to illustrate environmental assessment strategies for “nonclassical” drugs with unique physical-chemical properties\, unique modalities\, etc.\nLessons learned and perspectives on current regulatory framework for environmental assessment\n\nIndustry Perspective on New EMA Guidelines\nSpeaker: Dr. Jessica Vestel\, Merck \n\nKey changes to new guidance\nPredicted impacts to industry\n\nSeating at this free seminar is limited. Please RSVP by July 29\, 2019
URL:https://scienceinboston.com/event/overview-of-the-anticipated-environmental-risk-assessment-guideline-revisions-with-selected-case-studies-and-perspectives-from-industry-experts/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190805T093000
DTEND;TZID=America/New_York:20190805T140000
DTSTAMP:20190723T202609Z
CREATED:20190723T202609Z
LAST-MODIFIED:20190723T202609Z
UID:27300-1564997400-1565013600@scienceinboston.com
SUMMARY:Overview of the Anticipated Environmental Risk Assessment Guideline Revisions\, with Selected Case Studies and Perspectives from Industry Experts
DESCRIPTION:Presentation Topics: \nNotable Changes to the Existing European Medicines Agency Guideline for ERA: How Revisions Could Affect Testing and Environmental Risk Assessment of Human Drugs\nSpeaker: Dr. Erick Nfon\, Smithers Viscient \n\nIntroduction of a decision tree that clarifies when ERA studies are required\nNew guidance for the estimation of exposure to human pharmaceuticals via the food chain (secondary poisoning)\nRevision to the tiered approach to laboratory testing\nIntroduction of tailored risk assessments for active substances with specific modes of action\, e.g. antimicrobials and Endocrine Active Substances\n\nEnvironmental Assessment of New Human Drugs: Case studies and Lessons Learned\nSpeaker: Dr. Tim Verslycke\, Gradient \n\nChanges in drug R&D are increasingly requiring a tailored environmental assessment approach\nReal case studies to illustrate environmental assessment strategies for “nonclassical” drugs with unique physical-chemical properties\, unique modalities\, etc.\nLessons learned and perspectives on current regulatory framework for environmental assessment\n\nIndustry Perspective on New EMA Guidelines\nSpeaker: Dr. Jessica Vestel\, Merck \n\nKey changes to new guidance\nPredicted impacts to industry\n\nSeating at this free seminar is limited. Please RSVP by July 29\, 2019
URL:https://scienceinboston.com/event/overview-of-the-anticipated-environmental-risk-assessment-guideline-revisions-with-selected-case-studies-and-perspectives-from-industry-experts-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190805T080000
DTEND;TZID=America/Vancouver:20190809T170000
DTSTAMP:20190723T202345Z
CREATED:20190723T202345Z
LAST-MODIFIED:20190723T202345Z
UID:5989-1564992000-1565370000@scienceinboston.com
SUMMARY:Advanced Industrial Bioprocessing Professional Short Course
DESCRIPTION:Course Outline: The trainees will learn core principles and concepts of industrial bioprocessing of protein\, cell and gene therapies. The course covers key concepts and practices of upstream\, downstream and analytical bioprocessing technologies. In addition\, FDA initiatives of PAT (Process Analytical Technology)\, Quality by Design\, and Emerging Technology will be covered. The course consists of 7 modules. \nCourse Modules: \nModule 1\, Upstream Bioprocessing \nModule 2\, Downstream Bioprocessing \nModule 3\, Analytical Technology in Bioprocessing \nModule 4\, Cell Therapy & Bioprocessing \nModule 5\, Gene Therapy & Bioprocessing \nModule 6\, Regulatory\, QbD\, and PAT in Bioprocessing \nModule 7\, Systems Biotechnology
URL:https://scienceinboston.com/event/advanced-industrial-bioprocessing-professional-short-course/
LOCATION:UMass Lowell\, UMass Lowell\, Lowell\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190805T080000
DTEND;TZID=America/Vancouver:20190809T170000
DTSTAMP:20190723T202345Z
CREATED:20190723T202345Z
LAST-MODIFIED:20190723T202345Z
UID:27299-1564992000-1565370000@scienceinboston.com
SUMMARY:Advanced Industrial Bioprocessing Professional Short Course
DESCRIPTION:Course Outline: The trainees will learn core principles and concepts of industrial bioprocessing of protein\, cell and gene therapies. The course covers key concepts and practices of upstream\, downstream and analytical bioprocessing technologies. In addition\, FDA initiatives of PAT (Process Analytical Technology)\, Quality by Design\, and Emerging Technology will be covered. The course consists of 7 modules. \nCourse Modules: \nModule 1\, Upstream Bioprocessing \nModule 2\, Downstream Bioprocessing \nModule 3\, Analytical Technology in Bioprocessing \nModule 4\, Cell Therapy & Bioprocessing \nModule 5\, Gene Therapy & Bioprocessing \nModule 6\, Regulatory\, QbD\, and PAT in Bioprocessing \nModule 7\, Systems Biotechnology
URL:https://scienceinboston.com/event/advanced-industrial-bioprocessing-professional-short-course-2/
LOCATION:UMass Lowell\, UMass Lowell\, Lowell\, MA\, United States
END:VEVENT
END:VCALENDAR